Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bone marrow collection in healthy volunteers for preclinical spinal cord injury cell-therapy development
NL-OMON44780Recruiting
- Sponsor
- Maastricht University
- Start
- Jul 2015
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Open-label, single-arm trial of autologous bone marrow-derived stem cells in spinal cord injury (SCI), sponsored by Maastricht University. Primary endpoints: Manufacturing process installation and adjustment and Product characterization. Started Jul 2015; status: recruiting.
02
Drugs
autologous bone marrow-derived stem cells
03
Conditions
spinal cord injury (SCI)
Beyond the preview
Go deeper on NL-OMON44780.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON44780.